Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA111773 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:High Resolution Copy Number Analysis of Paraffin Embedded Archival Tissue Using SNP BeadArrays
| PRJNA96207 | ENA
Project description:41 lung adenocarcinoma from never-smokers hybridized on Illumina SNP arrays on 13 HumanCNV370-Quadv3 chips. High-resolution array comparative genomic hybridization analysis of lung adenocarcinoma in 41 never smokers for identification of new minimal common regions (MCR) of gain or loss. The SNP array analysis validated copy-number aberrations and revealed that RB1 and WRN were altered by recurrent copy-neutral loss of heterozygosity.The present study has uncovered new aberrations containing cancer genes. The oncogene FUS is a candidate gene in the 16p region that is frequently gained in never smokers. Multiple genetic pathways defined by gains of MYC, deletions of RB1 and WRN or gains on 7p and 7q are involved in lung adenocarcinoma in never smokers. A 'Cartes d'Identite des Tumeurs' (CIT) project from the French National League Against Cancer (http://cit.ligue-cancer.net) 41 samples hybridized on Illumina SNP arrays. Submitter : Fabien PETEL petelf@ligue-cancer.net . Project leader : Pr Pierre FOURET pierre.fouret@psl.aphp.fr
2011-07-28 | E-TABM-1169 | biostudies-arrayexpress
Project description:High-resolution mapping of copy-number alterations with massively parallel sequencing
| PRJNA113945 | ENA
Project description:High-resolution mapping of copy-number alterations with massively parallel sequencing
| PRJNA30559 | ENA
Project description:High-resolution genome-wide copy number analysis of low grade serous ovarian tumours
| PRJNA254778 | ENA
Project description:High-resolution genome-wide copy number analysis of pre-invasive mucinous ovarian tumours
| PRJNA170106 | ENA
Project description:A High-Resolution Copy Number Variation Resource for Clinical Genetics
| PRJNA256015 | ENA
Project description:High-resolution aCGH analyses of copy number alterations in HER2-amplified breast cancer
| PRJNA126281 | ENA